Literature DB >> 11812428

Vision loss among diabetics in a group model Health Maintenance Organization (HMO).

Donald S Fong1, Mohktar Sharza, Wansu Chen, John F Paschal, Reginald G Ariyasu, Paul P Lee.   

Abstract

PURPOSE: To report the management of diabetic retinopathy in one group model health maintenance organization and assess the quality of care.
METHODS: Cross-sectional study. A chart review of 1200 randomly identified patients with diabetes mellitus, continuously enrolled for 3 years in Kaiser Permanente (KP) Southern California, the largest provider of managed care in Southern California, was performed. A total of 1047 patients were included in the analyses. Patient characteristics as well as information from the last eye examination were abstracted. Charts from patients with visual acuity less than 20/200 in their better eye (legal blindness) were selected for extensive chart review to determine the cause of visual loss and the antecedent process of care. T tests or the Wilcoxon rank sum test was used to compare continuous variables. The chi(2) test or the Fisher exact test was used to compare categorical variables. All analyses were performed on the Statistical Analyses System (SAS Institute, North Carolina).
RESULTS: Our study population of 1047 diabetic patients was 51.7% male, had a mean age of 60.4 years, a mean duration of diabetes of 9.6 years, and a mean hemoglobin A1c of 8.3%. During the study period, 77.5% of patients received a screening eye examination with examination by an ophthalmologist, an optometrist, or review of a retinal photograph. Of those with a visual acuity assessment (n = 687, 65.6% of 1047), 1.5% had visual acuity of 20/200 or worse (legally blind) in the better eye, while 8.2% had this level of visual acuity in the worse eye. Of eyes with new onset clinically significant macular edema and visual acuity < 20/40, 40% had documentation of focal laser performed within 1 month of diagnosis. Of eyes with vitreous hemorrhage and visual acuity < 20/40, 50% had documentation of vitrectomy. Among eyes that had vitrectomy, over 80% had this procedure within 1 year of diagnosis of vitreous hemorrhage.
CONCLUSIONS: The current report is the largest study of diabetic retinopathy outcomes among patients enrolled in a prepaid health plan. Further research is necessary to investigate the impact of managed care on health outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 11812428     DOI: 10.1016/s0002-9394(01)01364-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

Review 1.  Retinal imaging and image analysis.

Authors:  Michael D Abràmoff; Mona K Garvin; Milan Sonka
Journal:  IEEE Rev Biomed Eng       Date:  2010

2.  Automated detection of clinically significant macular edema by grid scanning optical coherence tomography.

Authors:  Srinivas R Sadda; Ou Tan; Alexander C Walsh; Joel S Schuman; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2006-05-02       Impact factor: 12.079

3.  Automated detection of diabetic retinopathy: barriers to translation into clinical practice.

Authors:  Michael D Abramoff; Meindert Niemeijer; Stephen R Russell
Journal:  Expert Rev Med Devices       Date:  2010-03       Impact factor: 3.166

Review 4.  The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management.

Authors:  Delia Cabrera DeBuc
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

5.  Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa.

Authors:  R Kahloun; B Jelliti; S Zaouali; S Attia; S Ben Yahia; S Resnikoff; M Khairallah
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

6.  Use of electronic health records and administrative data for public health surveillance of eye health and vision-related conditions in the United States.

Authors:  Amanda F Elliott; Arthur Davidson; Flora Lum; Michael F Chiang; Jinan B Saaddine; Xinzhi Zhang; John E Crews; Chiu-Fang Chou
Journal:  Am J Ophthalmol       Date:  2012-12       Impact factor: 5.258

7.  Promise of endothelial progenitor cell for treatment of diabetic retinopathy.

Authors:  Ashay D Bhatwadekar; Lynn C Shaw; Maria B Grant
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

8.  Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.

Authors:  Lexi Ding; Rui Cheng; Yang Hu; Yusuke Takahashi; Alicia J Jenkins; Anthony C Keech; Kenneth M Humphries; Xiaowu Gu; Michael H Elliott; Xiaobo Xia; Jian-Xing Ma
Journal:  Am J Pathol       Date:  2014-08-07       Impact factor: 4.307

9.  Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.

Authors:  Niels de Fine Olivarius; Volkert Siersma; Gitte Juul Almind; Niels Vesti Nielsen
Journal:  BMC Public Health       Date:  2011-02-04       Impact factor: 3.295

10.  Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.

Authors:  Ying Chen; Yang Hu; Mingkai Lin; Alicia J Jenkins; Anthony C Keech; Robert Mott; Timothy J Lyons; Jian-xing Ma
Journal:  Diabetes       Date:  2012-10-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.